Furthermore, radiomic profiling has significant advantages and broad applicability in the diagnosis, prognosis prediction, and selection of suitable treatment options for tumors, which can aid in the early and non-invasive assessment of GPC3 expression in patients with HCC (10). Here, GPC3 is linked to hepatocellular carcinoma.